Methylglyoxal Metabolism and Aging-Related Disease: Moving from Correlation toward Causation

Publication date: Available online 19 November 2019Source: Trends in Endocrinology & MetabolismAuthor(s): Rasmus Kold-Christensen, Mogens JohannsenMethylglyoxal (MG) is a ubiquitous metabolite that spontaneously reacts with biopolymers forming advanced glycation end-products (AGEs). AGEs are strongly associated with aging-related diseases, including cancer, neurodegenerative diseases, and diabetes. As the formation of AGEs is nonenzymatic, the damage caused by MG and AGEs has been regarded as unspecific. This may have resulted in the field generally been regarded as unappealing by many researchers, as detailed mechanisms have been difficult to probe. However, accumulating evidence highlighting the importance of MG in human metabolism and disease, as well as data revealing how MG can elicit its signaling function via specific protein AGEs, could change the current mindset, accelerating the field to the forefront of future research.
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research